Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castrate-resistant Prostate (CRPC) Cancer”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableStudy completedNCT03329742
What this trial is testing

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Indiana University 2
Early research (Phase 1)Study completedNCT01792687
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 6
Early research (Phase 1)Ended earlyNCT01741753
What this trial is testing

BKM120+Abiraterone Acetate for Metastatic CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT01558492
What this trial is testing

Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 3
Large-scale testing (Phase 3)Study completedNCT02887976
What this trial is testing

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Who this might be right for
Prostate Cancer
GU Research Network, LLC 2
Testing effectiveness (Phase 2)UnknownNCT02266745
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Who this might be right for
Advanced Solid TumorsCRPCmCRPC+6 more
Promontory Therapeutics Inc. 109
Not applicableStudy completedNCT02376296
What this trial is testing

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Saladax Biomedical, Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT01352208
What this trial is testing

Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Castrate Resistant Prostate Cancer
Astellas Pharma Inc 13
Large-scale testing (Phase 3)Ended earlyNCT02438007
What this trial is testing

Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 953
Early research (Phase 1)WithdrawnNCT02864784
What this trial is testing

Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC

Who this might be right for
Castrate Resistant Prostate Cancer With Bone Metastasis
Amorphical Ltd.
Not applicableStudy completedNCT04995614
What this trial is testing

Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223

Who this might be right for
Castrate Resistant Prostate CancerBone Metastases
Radboud University Medical Center 122
Testing effectiveness (Phase 2)Study completedNCT01834651
What this trial is testing

A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases

Who this might be right for
Prostate Cancer
Edwin Posadas, MD 17
Early research (Phase 1)Study completedNCT02204072
What this trial is testing

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Boehringer Ingelheim 120
Testing effectiveness (Phase 2)Study completedNCT02159950
What this trial is testing

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT01599793
What this trial is testing

Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Who this might be right for
Bone MetastasesCastrate-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Chicago 19
Testing effectiveness (Phase 2)Study completedNCT01942837
What this trial is testing

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 67
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Large-scale testing (Phase 3)Ended earlyNCT01083615
What this trial is testing

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castrate-Resistant Prostate CancerHormone Refractory Prostate Cancer
Achieve Life Sciences 14
Post-approval studies (Phase 4)UnknownNCT03432949
What this trial is testing

Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 24
Testing effectiveness (Phase 2)Study completedNCT01051570
What this trial is testing

Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 26
Next Page